We are live on
!
Find out more
LG
LaFleur & Godfrey Portfolio holdings
AUM
$842M
1-Year Est. Return
24.12%
This Fund
S&P 500
This Quarter
Est. Return
+10.24%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$671M
AUM Growth
+$46.1M
(+7.4%)
Cap. Flow
-$11.1M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
37.83%
Holding
144
New
18
Increased
37
Reduced
62
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$4.97M |
| 2 |
Zoetis
ZTS
|
+$3.69M |
| 3 |
Mercury Systems
MRCY
|
+$3.31M |
| 4 |
IBM
IBM
|
+$2.63M |
| 5 |
ExxonMobil
XOM
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$14.8M |
| 2 |
Danaher
DHR
|
+$3.27M |
| 3 |
ResMed
RMD
|
+$2.43M |
| 4 |
Alcon
ALC
|
+$2.16M |
| 5 |
Automatic Data Processing
ADP
|
+$1.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Healthcare | 24.93% |
| 3 | Industrials | 15.58% |
| 4 | Financials | 8.23% |
| 5 | Consumer Staples | 6.29% |
Similar funds
WF
EBSAM
KM
PCOC
PMWMG
AGA
LWA
FPF
LaFleur & Godfrey's Q4 2023 Portfolio in Review
As of Q4 2023, LaFleur & Godfrey held 144 positions worth $671M, up 7.4% from $625M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
LaFleur & Godfrey's Q4 2023 filing shows 18 new, 37 increased, 62 reduced and 8 closed positions. Its largest new stake was Honeywell: 27,555 shares worth $5.45M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $14.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
- LaFleur & Godfrey's largest Q4 2023 buy was Honeywell: 27,555 shares worth $5.45M.
- LaFleur & Godfrey added most to Zoetis in Q4 2023, an estimated $3.69M increase.
- LaFleur & Godfrey's biggest Q4 2023 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $14.8M.
- LaFleur & Godfrey fully exited ResMed in Q4 2023, selling an estimated $2.43M.
- LaFleur & Godfrey's ten largest holdings make up 38% of its $671M portfolio in Q4 2023.
- LaFleur & Godfrey opened 18 new positions and closed 8 in Q4 2023.
- LaFleur & Godfrey's portfolio value rose 7.4% quarter-over-quarter to $671M.
Based on LaFleur & Godfrey's 13F filing for Q4 2023, filed 18 Jan 2024.